Novelion Therapeutics Inc. announced the appointment of Jeffrey Hackman as Executive Vice President and Chief Operating Officer, effective November 1, 2017. Jeffrey Hackman was most recently senior vice president, head of the US Internal Medicine and Oncology franchises for Shire. In this role, Mr. Hackman was a member of the US commercial leadership team and was responsible for sales, marketing, business insights and analytics for eight licensed products within Shire's US rare disease portfolio.